These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1323911)

  • 1. [Determination of the protonation constants of pipecuronium bromide on the basis of optical rotation as a function of pH values].
    Bertháné SZ; Papné SZ
    Acta Pharm Hung; 1992 May; 62(3):111-4. PubMed ID: 1323911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of steroids. Part 44: Analytical investigation of the intermediates of the synthesis of pipecuronium bromide (Arduan)].
    Laukó A; Horváth P; Trischler F; Görög S
    Acta Pharm Hung; 1992 May; 62(3):82-7. PubMed ID: 1323917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmaceutic development of injectable Arduan].
    Deákné RE; Guti Z; Rádi E
    Acta Pharm Hung; 1992 May; 62(3):115-20. PubMed ID: 1323912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Excerpts from the investigations of pipecuronium bromide with NMR spectroscopy].
    Balogh G; Tuba Z
    Acta Pharm Hung; 1992 May; 62(3):97-102. PubMed ID: 1323919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mass spectrometry of pipecuronium bromide and some related compounds].
    Mák M; Tamás J; Mahó S; Tuba Z
    Acta Pharm Hung; 1992 May; 62(3):103-9. PubMed ID: 1323910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of steroids. Part 45: Analytical investigation of pipecuronium bromide (Arduan)].
    Gazdag M; Szepesi G; Mihályfi K; Kemenesné BP; Horváth P; Végh Z; Rényei M; Trischler F; Görög S
    Acta Pharm Hung; 1992 May; 62(3):88-96. PubMed ID: 1323918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis of a new neuromuscular blocking agent, pipecuronium bromide (Arduan)].
    Tuba Z; Mahó S
    Acta Pharm Hung; 1992 May; 62(3):73-81. PubMed ID: 1323916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacologic effects of pipecuronium bromide (Arduan)].
    Kárpáti E; Bíró K
    Acta Pharm Hung; 1992 May; 62(3):121-6. PubMed ID: 1323913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man].
    Yajima C; Sugai N; Hanaoka K; Numata K; Yamamoto K; Kushida Y; Murakami S; Yamamura H
    Masui; 1990 Jul; 39(7):882-9. PubMed ID: 1976829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics and metabolism of pipecuronium bromide (Arduan)].
    Vereczkey L
    Acta Pharm Hung; 1992 May; 62(3):127-31. PubMed ID: 1323914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pipecuronium bromide.
    Benad G; Hofmockel R
    Br J Hosp Med; 1991 May; 45(5):308. PubMed ID: 1648418
    [No Abstract]   [Full Text] [Related]  

  • 13. [A pharmacodynamic study of pipecuronium bromide (Arduan) in newborn infants, infants and children].
    Praefort L
    Cah Anesthesiol; 1990 Mar; 38(2):79-85. PubMed ID: 2163731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopharmacology of Arduan].
    Mészáros C
    Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antagonism of the neuromuscular block by pipecuronium bromide during anesthesia with isoflurane. A comparative study in elderly and adult patients].
    Valeri R; Montorsi E; Gioia L; Martani C; Torri G
    Minerva Anestesiol; 1990 Sep; 56(9):899-903. PubMed ID: 2177168
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations on the neuromuscular blocking action of pipecuronium in the dog.
    Jones RS
    Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and disposition of pipecuronium bromide in the cat.
    Agoston S; Vandenbrom RH; Wierda JM; Houwertjes MC; Kersten UW
    Eur J Anaesthesiol; 1988 Jul; 5(4):233-42. PubMed ID: 2848702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetic study of the hydrolysis of pipecuronium bromide. I Separation and quantitative determination of pipecuronium bromide and its hydrolysis-derivatives by thin-layer chromatography and densitometry].
    Kovács P; Takácsi Nagy G
    Acta Pharm Hung; 1983 Mar; 53(2):56-63. PubMed ID: 6310952
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.